PR
Immutep Ltd
PRRUF · OTC
$0.04 -5.25% (-$0.00)
Market Cap $82.8M
P/E Ratio -
Div. Yield -
ROE 66.49%
Piotroski F-Score Moderate
4/9Valuation
64 /100
Fair P/S 5.70x
P/B 1.35x
P/E N/A
Growth
78 /100
Growing Rev. growth 60.66%
Book val. growth 23.35%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 83.01%
FCF margin 381.65%
Net margin 544.79%
Quality
2 /100
Poor ROIC 120.87%
Asset turnover 0.17x
ROE 66.49%
Debt
69 /100
Low Debt/Equity 0.02x
Int. coverage -1,235.43x
Current ratio 5.69x
Stability
23 /100
Unstable Beta 2.20x
Profitable years 0
Rev. volatility 97.47%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o PRRUF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marc Voigt
Employees
1,027
Headquarters
Sydney
Nadchodzące wydarzenia
25 LUT
Earnings
Upcoming earnings report